Odysseas Kostas

Odysseas Kostas

Presidente en AMARIN CORPORATION PLC .

Fortuna: 242 273 $ al 31/05/2026

51 años
Health Technology
Finance
Commercial Services

Perfil

Odysseas Demosthenes Kostas is currently Chairman at Amarin Corp.
Plc since 2023 and Independent Director at Armata Pharmaceuticals, Inc. since 2020.
Former positions include President & Chief Executive Officer at Essentialis, Inc., Independent Director at Enzon Pharmaceuticals, Inc. from 2013 to 2020, Director at Mast Therapeutics, Inc. from 2010 to 2011, Director at International Strategy & Investment Group LLC from 2011 to 2015, Director at International Strategy & Investment, Inc. from 2011 to 2015, Senior Managing Director at Sarissa Capital Acquisition Corp.
from 2020 to 2023, Director at Innoviva, Inc. from 2020 to 2025, Vice President-Marketing at KOS Pharmaceuticals, Inc., and Member at Yale New Haven Health Services Corp.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from The University of Texas Southwestern Medical Center.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/04/2026 16.720 ( 0 % ) 242 273 $ 31/05/2026
17/04/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Odysseas Kostas

EmpresasCargoInicio
ARMATA PHARMACEUTICALS, INC. Director/Miembro de la Junta 12/02/2020
AMARIN CORPORATION PLC Presidente 27/03/2023

Antiguos cargos conocidos de Odysseas Kostas.

EmpresasCargoFin
INNOVIVA, INC. Presidente 01/12/2020
SARISSA CAPITAL ACQUISITION CORP. Corporate Officer/Principal 13/04/2023
Director/Miembro de la Junta 04/08/2020
Director/Miembro de la Junta 01/12/2015
Director/Miembro de la Junta 01/12/2015
Ver el detalle de la experiencia de Odysseas Kostas.

Formación de Odysseas Kostas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

92

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

Finance

Commercial Services

Health Technology

Consumer Services

Health Technology

Finance

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN